However, the mentioned changes in M30 levels in the PCOS-PIR group did not reach statistical significance and patient number with sNASH in our groups is low.
← all excerpts
Liver Injury Indicating Fatty Liver but Not Serologic NASH Marker Improves under Metformin Treatment in Polycystic Ovary Syndrome.
1
—
—